DOI:
10.1055/s-00000181
Journal of Neurological Surgery Part B: Skull Base
LinksClose Window
References
Lok SW, Whittle JR, Vaillant F. et al.
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2-positive metastatic breast cancer.
Cancer Discov 2019;
9 (03) 354-369
We do not assume any responsibility for the contents of the web pages of other providers.